Interfering vaccine: a novel antiviral that converts a potentially virulent infection into one that is subclinical and immunizing. (Q30342528)

20 June 2017

Interfering vaccine: a novel antiviral that converts a potentially virulent infection into one that is subclinical and immunizing. (English)

1 reference

20 June 2017

0 references

3

Nigel J Dimmock

1 reference

20 June 2017

2

Lesley McLain

1 reference

20 June 2017

Simon Noble

1

1 reference

PubMed ID

15297051

20 June 2017

language of work or name

English

0 references

publication date

1 August 2004

1 reference

20 June 2017

1 reference

20 June 2017

22

1 reference

20 June 2017

23-24

1 reference

20 June 2017

3018-3025

1 reference

Characterization of an avian influenza A (H5N1) virus isolated from a child with a fatal respiratory illness

20 June 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.013

Human infection with influenza H9N2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.013

Characterization of the pathogenicity of members of the newly established H9N2 influenza virus lineages in Asia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.013

Characterization of a human H9N2 influenza virus isolated in Hong Kong

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.013

Lack of evidence for human-to-human transmission of avian influenza A (H9N2) viruses in Hong Kong, China 1999

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.013

Structural basis of immune recognition of influenza virus hemagglutinin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.013

Immunity to influenza in the elderly

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.013

Live attenuated intranasal influenza vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.013

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.013

7 January 2021

Antiviral developments

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.013

Panel summary of international pandemic influenza plans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.013

Virology. The origin and control of pandemic influenza.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.013

Influenza vaccines: new developments.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.013

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.013

Defective Viral Particles and Viral Disease Processes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.013

Heterologous protection of mice from a lethal human H1N1 influenza A virus infection by H3N8 equine defective interfering virus: comparison of defective RNA sequences isolated from the DI inoculum and mouse lung

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.013

Protection of mice from lethal influenza: evidence that defective interfering virus modulates the immune response and not virus multiplication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.013

Defective interfering type A equine influenza virus (H3N8) protects mice from morbidity and mortality caused by homologous and heterologous subtypes of influenza A virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.013

Protection of three strains of mice against lethal influenza in vivo by defective interfering virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.013

Intracellular stability of the interfering activity of a defective interfering influenza virus in the absence of virus multiplication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.013

Defective RNAs inhibit the assembly of influenza virus genome segments in a segment-specific manner

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.013

Defective segment 1 RNAs that interfere with production of infectious influenza A virus require at least 150 nucleotides of 5' sequence: evidence from a plasmid-driven system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.013

Cross-protection against a lethal influenza virus infection by DNA vaccine to neuraminidase.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.013

A universal influenza A vaccine based on the extracellular domain of the M2 protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.013

Defective influenza A virus generated entirely from plasmids: its RNA is expressed in infected mouse lung and modulates disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.013

Defective interfering viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.013

Defective interfering viruses and infections of animals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.013

inferred from DOI database lookup

7 January 2021

based on heuristic

Passively transferred monoclonal antibody to the M2 protein inhibits influenza A virus replication in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.013

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VACCINE.2004.02.013

1 reference

20 June 2017

1 reference

PubMed ID

15297051